Sep 2026
CD24 interacts with EDN1 to activate NFκB signaling driving triple-negative breast cancer tumor progression and paclitaxel resistance.
The CD24-EDN1-NFκB axis has a crucial role in PTX resistance in TNBC, according to this study, offering a new therapeutic target for treating chemotherapy resistance.
Ying-Cheng Deng, Jun-Jie Tian, Li-Jun Zhang et al.
· Biochimica et Biophysica Act... · 0 citations